These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 29951872

  • 21. Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in Faslpr Mice.
    Zhou Y, Chen H, Liu L, Yu X, Sukhova GK, Yang M, Kyttaris VC, Stillman IE, Gelb B, Libby P, Tsokos GC, Shi GP.
    J Immunol; 2017 Mar 01; 198(5):1846-1854. PubMed ID: 28093526
    [Abstract] [Full Text] [Related]

  • 22. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 01; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 23. Overexpression of Epstein-Barr virus-induced gene 3 protein (EBI3) in MRL/lpr mice suppresses their lupus nephritis by activating regulatory T cells.
    Shinsuke N, Hiroshi I.
    Autoimmunity; 2013 Nov 01; 46(7):446-54. PubMed ID: 23845089
    [Abstract] [Full Text] [Related]

  • 24. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ.
    J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682
    [Abstract] [Full Text] [Related]

  • 25. Effect of a novel immunosuppressant, FK506, on spontaneous lupus nephritis in MRL/MpJ-lpr/lpr mice.
    Entani C, Izumino K, Iida H, Fujita M, Asaka M, Takata M, Sasayama S.
    Nephron; 1993 Sep 15; 64(3):471-5. PubMed ID: 7688103
    [Abstract] [Full Text] [Related]

  • 26. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B, Ye H, You X, Ni H, Chen X, Li L.
    Life Sci; 2018 Sep 01; 208():26-32. PubMed ID: 30146016
    [Abstract] [Full Text] [Related]

  • 27. Glomerular cytokine expression in murine lupus nephritis.
    Tshilela KA, Ikeuchi H, Matsumoto T, Kuroiwa T, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.
    Clin Exp Nephrol; 2016 Feb 01; 20(1):23-9. PubMed ID: 25985839
    [Abstract] [Full Text] [Related]

  • 28. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlöndorff D.
    Kidney Int; 2004 Sep 01; 66(3):1018-28. PubMed ID: 15327395
    [Abstract] [Full Text] [Related]

  • 29. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models.
    Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, Kakimoto T, Utsumi H, Oshita K, Kataoka H.
    J Immunol Res; 2019 Sep 01; 2019():5821589. PubMed ID: 31930150
    [Abstract] [Full Text] [Related]

  • 30. Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway.
    Chen XC, Wu D, Wu HL, Li HY, Yang C, Su HY, Liu ZJ, Huang XR, Lu X, Huang LF, Zhu SP, Pan QJ, An N, Liu HF.
    Lupus Sci Med; 2022 Apr 01; 9(1):. PubMed ID: 35414608
    [Abstract] [Full Text] [Related]

  • 31. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.
    Immunol Lett; 2015 Dec 01; 168(2):355-65. PubMed ID: 26545567
    [Abstract] [Full Text] [Related]

  • 32. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z, Wong CK, Dong J, Chu M, Jiao D, Kam NW, Lam CW, Tam LS.
    Clin Exp Immunol; 2015 Aug 01; 181(2):253-66. PubMed ID: 25845911
    [Abstract] [Full Text] [Related]

  • 33. The new complement inhibitor CRIg/FH ameliorates lupus nephritis in lupus-prone MRL/lpr mice.
    Shi Y, Yao W, Sun L, Li G, Liu H, Ding P, Hu W, Xu H.
    BMC Nephrol; 2019 Nov 21; 20(1):424. PubMed ID: 31752725
    [Abstract] [Full Text] [Related]

  • 34. Amelioration of autoimmune nephritis by imatinib in MRL/lpr mice.
    Sadanaga A, Nakashima H, Masutani K, Miyake K, Shimizu S, Igawa T, Sugiyama N, Niiro H, Hirakata H, Harada M.
    Arthritis Rheum; 2005 Dec 21; 52(12):3987-96. PubMed ID: 16320345
    [Abstract] [Full Text] [Related]

  • 35. Blockage of TIM-3 relieves lupus nephritis by expanding Treg cells and promoting their suppressive capacity in MRL/lpr mice.
    Gao YF, Lu YY, Fan XZ, Wang YH, Tian JH, Saed YA, Li RS, Zhou XS.
    Int Immunopharmacol; 2022 Sep 21; 110():108971. PubMed ID: 35777268
    [Abstract] [Full Text] [Related]

  • 36. Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/lpr mice.
    Ito T, Seo N, Yagi H, Ohtani T, Tokura Y, Takigawa M, Furukawa F.
    J Dermatol Sci; 2002 Apr 21; 28(3):198-210. PubMed ID: 11912007
    [Abstract] [Full Text] [Related]

  • 37. CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus.
    Chalmers SA, Wen J, Shum J, Doerner J, Herlitz L, Putterman C.
    Clin Immunol; 2017 Dec 21; 185():100-108. PubMed ID: 27570219
    [Abstract] [Full Text] [Related]

  • 38. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice].
    Wang ZH, Zhang W, Zhang YQ, Pang CY, Wang YF.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct 18; 48(5):771-776. PubMed ID: 27752154
    [Abstract] [Full Text] [Related]

  • 39. SERPINB3 Delays Glomerulonephritis and Attenuates the Lupus-Like Disease in Lupus Murine Models by Inducing a More Tolerogenic Immune Phenotype.
    Gatto M, Luisetto R, Ghirardello A, Cavicchioli L, Codolo G, Biasiolo A, Maggioni G, Saccon F, Beggio M, Cappon A, Venturini R, Pontisso P, Doria A.
    Front Immunol; 2018 Oct 18; 9():2081. PubMed ID: 30254646
    [Abstract] [Full Text] [Related]

  • 40. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX, Deng XM, Wang QT, Sun XJ, Wei W.
    Acta Pharmacol Sin; 2015 Nov 18; 36(11):1367-76. PubMed ID: 26456588
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.